Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service

Scipher Medicine Appoints Richard Blackburn to its Advisory Board


Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced the appointment of Richard Blackburn to its advisory board.

Blackburn spent more than three decades at Sterling-Winthrop, Sanofi, Parke-Davis, and Pfizer. Most recently he was global president for Inflammation and Immunology at Pfizer, leading its multi-billion-dollar therapeutic business in autoimmune diseases.

"Finding the right medicine for patients with autoimmune conditions is difficult and often relies on trial and error, which takes time, consumes resources and, most importantly, delays the improvement so desperately needed by people suffering from these diseases," said Blackburn. "Scipher Medicine is bringing forward innovative precision medicine solutions that benefit patients, physicians, and the healthcare system. I'm proud to be a part of this important mission."

"We are pleased to welcome Richard to the team," said Alif Saleh, chief executive officer of Scipher Medicine. "His experience in the autoimmune drug markets will greatly benefit the team and our ability to navigate the healthcare system to ensure our precision medicine solutions reach all patients."

Blackburn's addition to the advisory board follows last month's appointment of pharma leader Dr. Michael Elliott, former senior vice president of Immunology at Janssen Pharmaceuticals.

About Scipher Medicine®
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectratm, our proprietary network medicine platform, we commercialize tests revealing a person's unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.


These press releases may also interest you

at 05:05
Zuora, Inc. , a leading monetization suite for modern business, today announced that global video game publisher Ubisoft has adopted Zuora to power its Ubisoft+ and Rocksmith+ subscription services. Over the course of the partnership, Ubisoft has...

at 05:02
Stax LLC, a global strategy consulting firm specializing in commercial due diligence, value creation, and exit planning for private equity firms, PE-backed companies, hedge funds, and investment banks has appointed Andrew Keller to the role of...

at 05:00
VdoCipher, a leading provider of video player and piracy protection solutions for content creators, e-learning, and media platforms, has announced significant success in combating video piracy with its latest innovation, the Piracy Tracker Engine. In...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...

at 05:00
Sulpayments Switzerland and GameCash Mexico, have announced their consolidation under a unified holding structure. This strategic move aims to leverage synergies between the two companies, combining Sulpayments' expertise in secure and efficient...

at 05:00
The innovator in jewelry and watch valuation software, Instappraise harnesses the power of technology to deliver a seamless user experience through its cutting-edge platform. Initially focused on integrating technological advancements into the...



News published on and distributed by: